Akebia Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $347k | 249k | 1.39 |
| 2025-12-31 | $343k | 213k | 1.61 |
| 2025-09-30 | $555k | 203k | 2.73 |
| 2025-06-30 | $668k | 183k | 3.65 |
| 2025-03-31 | $295k | 153k | 1.92 |
| 2024-12-31 | $263k | 138k | 1.91 |
| 2024-09-30 | $168k | 127k | 1.33 |
| 2024-06-30 | $130k | 127k | 1.03 |
| 2024-03-31 | $110k | 60k | 1.84 |
| 2023-12-31 | $75k | 60k | 1.25 |
| 2023-09-30 | $69k | 60k | 1.15 |
| 2023-06-30 | $76k | 83k | 0.92 |
| 2023-03-31 | $60k | 106k | 0.57 |
| 2022-12-31 | $96k | 167k | 0.58 |
| 2022-03-31 | $45k | 63k | 0.72 |
| 2021-12-31 | $100k | 45k | 2.25 |
| 2021-09-30 | $137k | 48k | 2.88 |
| 2021-06-30 | $174k | 46k | 3.78 |
| 2021-03-31 | $144k | 43k | 3.37 |
| 2020-12-31 | $120k | 43k | 2.81 |
| 2020-09-30 | $92k | 37k | 2.51 |
| 2020-06-30 | $375k | 28k | 13.59 |
| 2020-03-31 | $200k | 26k | 7.58 |
| 2019-12-31 | $162k | 26k | 6.32 |
| 2019-09-30 | $83k | 21k | 3.94 |
| 2019-06-30 | $99k | 20k | 4.85 |
| 2019-03-31 | $160k | 20k | 8.17 |
| 2018-12-31 | $107k | 19k | 5.52 |
| 2018-09-30 | $199k | 23k | 8.81 |
| 2018-06-30 | $222k | 22k | 9.96 |
| 2018-03-31 | $211k | 22k | 9.51 |